RenBio

RenBio delivers DNA therapeutics that allow for the in vivo bioproduction of antibody and protein therapeutics, fundamentally changing the use and global reach of antibody and protein therapies by overcoming prior limitations in administration, duration of efficacy, dosing frequency, and cost.